Skip to main content

Anika Therapeutics, Inc 10-Q for FY2022 Q1

Anika Therapeutics, Inc. (ANIK)

10-Q 2022-05-06 For: 2022-03-31
View Original
Added on April 06, 2026

About this 10-Q

Anika Therapeutics, Inc filed this 10-Q on May 6, 2022, covering the quarter ended March 31, 2022 (FY2022 Q1).

Headline figures

Quarter ended March 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$36.69M
up 7.0% from $34.29M a year earlier
Net loss
$2.93M
compared with net income of $2.84M a year earlier
Diluted EPS
-$0.20
compared with $0.20 a year earlier